IDiyas

For the Inventor, By the Inventor

Yeosu, South Korea

Ki-byung Chai

USPTO Granted Patents = 19

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 88(Granted Patents)


Location History:

  • Seoul, KR (1998 - 2004)
  • Yeosu, KR (2002 - 2004)
  • Junnam, KR (2003 - 2005)

Company Filing History:

goldMedal19 out of 796 
 
Florida State University Research Foundation, Inc.
 patents

Years Active: 1998-2005

Loading Chart...
19 patents (USPTO):Explore Patents
1. 6872842 - Butenyl substituted taxanes (2005-03-29),
2. 6797833 - C9 hydrido and acyloxy metal alkoxides (2004-09-28),
3. 6794523 - Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them (2004-09-21),
4. 6762309 - C7 acyloxy metal alkoxides (2004-07-13),
5. 6552205 - C10 OXO and hydrido taxane derivatives and pharmaceutical compositions containing them (2003-04-22),
6. 6521660 - 3′-alkyl substituted taxanes and pharmaceutical compositions containing them (2003-02-18),
7. 6482963 - C9 hydrido, hydroxy and acyloxy taxane derivatives and pharmaceutical compositions containing them (2002-11-19),
8. 6462208 - C7 acyloxy and hydrido taxane derivatives and pharmaceutical compositions containing them (2002-10-08),
9. 6395895 - Butenyl substituted &bgr;-lactams (2002-05-28),
10. 6335362 - Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them (2002-01-01),
11. 6018073 - Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted (2000-01-25),
12. 6011056 - C9 taxane derivatives and pharmaceutical compositions containing them (2000-01-04),
13. 6005138 - Tricyclic taxanes having a butenyl substituted side-chain and (1999-12-21),
14. 5998656 - C10 tricyclic taxanes (1999-12-07),
15. 5994576 - C7 tricyclic taxanes (1999-11-30),

Title: The Innovative Contributions of Ki-byung Chai in Taxane Derivatives

Introduction: Ki-byung Chai is a notable inventor based in Yeosu, South Korea, recognized for his significant contributions to the field of medicinal chemistry. With an impressive portfolio of 19 patents, Chai has focused primarily on the development of taxane derivatives, which are pivotal in cancer treatment research.

Latest Patents: Among his latest innovations are two key patents that showcase his expertise. The first is related to butenyl substituted taxanes, specifically taxane derivatives featuring a 3' butenyl substituted C13 side chain. The second patent involves C9 hydrido and acyloxy metal alkoxides, which are alternate taxane derivatives having innovative C9 substituents. These advancements highlight Chai's ongoing commitment to enhancing therapeutic options in oncology.

Career Highlights: Ki-byung Chai's career is marked by continuous research and innovation in the pharmaceutical field. He is affiliated with Florida State University, where his work merges academic excellence with cutting-edge research aimed at improving cancer treatments through novel chemical compounds.

Collaborations: Throughout his career, Chai has collaborated with esteemed colleagues such as Robert A. Holton and Hossain Nadizadeh. These partnerships not only enhance the quality of research but also widen the scope of discoveries that can emerge from his innovative work in taxane derivatives.

Conclusion: Ki-byung Chai's contributions to the field of medicinal chemistry have positioned him as a leading inventor in taxane research. His patents represent crucial steps forward in the fight against cancer and underscore the importance of sustained innovation in pharmacological sciences. As he continues to collaborate with other researchers, the potential for new discoveries remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…